89bio, Inc. (ETNB)
NASDAQ: ETNB · Real-Time Price · USD
10.25
+0.29 (2.91%)
At close: Jun 6, 2025, 4:00 PM
10.20
-0.05 (-0.49%)
After-hours: Jun 6, 2025, 5:05 PM EDT

89bio Statistics

Total Valuation

89bio has a market cap or net worth of $1.50 billion. The enterprise value is $898.06 million.

Market Cap 1.50B
Enterprise Value 898.06M

Important Dates

The next estimated earnings date is Monday, August 4, 2025, after market close.

Earnings Date Aug 4, 2025
Ex-Dividend Date n/a

Share Statistics

89bio has 145.98 million shares outstanding. The number of shares has increased by 43.38% in one year.

Current Share Class 145.98M
Shares Outstanding 145.98M
Shares Change (YoY) +43.38%
Shares Change (QoQ) +26.22%
Owned by Insiders (%) 0.56%
Owned by Institutions (%) 76.34%
Float 101.62M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.40
P/TBV Ratio 2.48
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 18.03, with a Debt / Equity ratio of 0.06.

Current Ratio 18.03
Quick Ratio 16.86
Debt / Equity 0.06
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -70.83

Financial Efficiency

Return on equity (ROE) is -69.30% and return on invested capital (ROIC) is -42.69%.

Return on Equity (ROE) -69.30%
Return on Assets (ROA) -39.93%
Return on Invested Capital (ROIC) -42.69%
Return on Capital Employed (ROCE) -62.32%
Revenue Per Employee n/a
Profits Per Employee -$4.16M
Employee Count 93
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, 89bio has paid $732,000 in taxes.

Income Tax 732,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +27.01% in the last 52 weeks. The beta is 1.53, so 89bio's price volatility has been higher than the market average.

Beta (5Y) 1.53
52-Week Price Change +27.01%
50-Day Moving Average 7.75
200-Day Moving Average 8.29
Relative Strength Index (RSI) 67.79
Average Volume (20 Days) 2,158,974

Short Selling Information

The latest short interest is 15.48 million, so 10.60% of the outstanding shares have been sold short.

Short Interest 15.48M
Short Previous Month 17.31M
Short % of Shares Out 10.60%
Short % of Float 15.23%
Short Ratio (days to cover) 10.23

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -403.29M
Pretax Income -170.51M
Net Income -386.67M
EBITDA -403.25M
EBIT -403.29M
Earnings Per Share (EPS) -$3.30
Full Income Statement

Balance Sheet

The company has $638.78 million in cash and $37.58 million in debt, giving a net cash position of $601.20 million or $4.12 per share.

Cash & Cash Equivalents 638.78M
Total Debt 37.58M
Net Cash 601.20M
Net Cash Per Share $4.12
Equity (Book Value) 605.46M
Book Value Per Share 4.15
Working Capital 645.06M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$399.84 million and capital expenditures -$87,000, giving a free cash flow of -$399.93 million.

Operating Cash Flow -399.84M
Capital Expenditures -87,000
Free Cash Flow -399.93M
FCF Per Share -$2.74
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

89bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -43.38%
Shareholder Yield -43.38%
Earnings Yield -25.79%
FCF Yield -26.68%
Dividend Details

Analyst Forecast

The average price target for 89bio is $26.43, which is 157.85% higher than the current price. The consensus rating is "Strong Buy".

Price Target $26.43
Price Target Difference 157.85%
Analyst Consensus Strong Buy
Analyst Count 8
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1